SPP-635

N/A

Report date: 2025/07/25 20:00:41
NME

Base Information

Drug NameSPP-635
Drug Alias NameSPP-630SPP-635
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRenin inhibitors
TargetsRenin
Therapy Area/IndicationsDiabetes Mellitus, Type 2Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyIreland
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma AgSpeedel Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSpeedel Pharma Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Hypertension

Other Information

ATC CodeN/A
Related LinksN/A